"Detection of a Small Admixture of Acetone in the Exhaled Air for Noninvasive Diagnosis
of Type I Diabetes"
A method for measuring the concentration of a biomarker (acetone in human's breath),
which is based on the use of glow-discharge emission spectroscopy in air is proposed for the purpose
of noninvasive glucose monitoring in diabetes patients' blood. The experimental setup and measure-
ment techniques are described, and preliminary results of clinical trials of the developed system under ambulatory conditions are presented. The patent for this development was registered in the Russian Federation. «METHOD OF MONITORING ACETONE LOW IMPURITIES IN THE EXPIRED AIR AND DEVICE FOR ITS IMPLEMENTATION» RU 2597943 (C1) 2015-07-15.
DOWNLOAD PATENT EN
DOWNLOAD PATENT RU
Clinical trials of Health monitor were conducted in an independent laboratory in Japan. Measurements were conducted with three types of patients: Type 1 diabetes for about 10 years, early stages of type 1 diabetes, and conditionally healthy patients. The results shows that the breath acetone level measured by Health monitor linearly depends on the amount of the blood glucose concentration of all persons examined. READ MORE